Cingulate Director Receives 15,000 Stock Options at $4.14 Strike Price
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Director Peter J. Werth of Cingulate received a stock option grant for 15,000 shares of common stock on June 20, 2025. The options were granted with an exercise price of $4.14 per share and will expire on June 20, 2035.
Key terms of the option grant:
- Vesting occurs at the earlier of: one-year anniversary of grant date or the 2026 annual stockholder meeting
- Transaction reported as a Form 4 filing indicating changes in beneficial ownership
- Options were acquired at no cost ($0) as part of director compensation
The filing was signed by Shane J. Schaffer as attorney-in-fact on June 23, 2025. This equity grant appears to be part of standard director compensation arrangements and represents a new beneficial ownership position for the reporting person.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) | 15,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2026 annual meeting of stockholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Peter J. Werth receive from CINGW on June 20, 2025?
When do Peter Werth's CINGW stock options vest?
What is Peter J. Werth's role at CINGW?
What was the total value of stock options granted to Peter Werth in this CINGW insider transaction?
Where is CINGW's Director Peter Werth located?
AI-generated analysis. How Rhea-AI works. Not financial advice.